High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study
ConditionBreast Cancer Female
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorInstitut Bergonié
About this trial
Monocentric prospective study evaluating the efficacy of High intensity focused ultrasound (HIFU) in breast tumors.
Eligibility criteria
Qualifiers
Histologically proven infiltrating ductal carcinoma with the analysis of hormone receptors, tumor grade, Her-2 expression.
T0 lesion, unifocal or plurifocal, with or without micro-calcifications associated, measuring 15 mm maximum major axis on ultrasound.
Clinical N0.
Bra cup size greater than or equal to B.
Disqualifiers
Infiltrating lobular carcinoma and Pure ductal carcinoma in situ.
Bilateral lesion.
Non-detectable MRI lesions, within 10 mm of the skin, greater than 15 mm on ultrasound.
Unifocal palpable tumor.
Trial design
Treatments tested in this trial
- High Instensity Focused Ultrasound
Treatment groups
15 Participants
are divided into 1 treatment groupSponsors and collaborators
Institut Bergonié
Lead sponsor
Ligue contre le cancer, France
Collaborator
Source ClinicalTrials.gov